| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.33 | 0.04 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.33 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |